...
首页> 外文期刊>Microbiome >Optimization and validation of sample preparation for metagenomic sequencing of viruses in clinical samples
【24h】

Optimization and validation of sample preparation for metagenomic sequencing of viruses in clinical samples

机译:优化和验证用于临床样品中病毒宏基因组测序的样品制备

获取原文

摘要

BackgroundSequence-specific PCR is the most common approach for virus identification in diagnostic laboratories. However, as specific PCR only detects pre-defined targets, novel virus strains or viruses not included in routine test panels will be missed. Recently, advances in high-throughput sequencing allow for virus-sequence-independent identification of entire virus populations in clinical samples, yet standardized protocols are needed to allow broad application in clinical diagnostics. Here, we describe a comprehensive sample preparation protocol for high-throughput metagenomic virus sequencing using random amplification of total nucleic acids from clinical samples. ResultsIn order to optimize metagenomic sequencing for application in virus diagnostics, we tested different enrichment and amplification procedures on plasma samples spiked with RNA and DNA viruses. A protocol including filtration, nuclease digestion, and random amplification of RNA and DNA in separate reactions provided the best results, allowing reliable recovery of viral genomes and a good correlation of the relative number of sequencing reads with the virus input. We further validated our method by sequencing a multiplexed viral pathogen reagent containing a range of human viruses from different virus families. Our method proved successful in detecting the majority of the included viruses with high read numbers and compared well to other protocols in the field validated against the same reference reagent. Our sequencing protocol does work not only with plasma but also with other clinical samples such as urine and throat swabs. ConclusionsThe workflow for virus metagenomic sequencing that we established proved successful in detecting a variety of viruses in different clinical samples. Our protocol supplements existing virus-specific detection strategies providing opportunities to identify atypical and novel viruses commonly not accounted for in routine diagnostic panels.
机译:背景技术序列特异性PCR是诊断实验室中最常见的病毒鉴定方法。但是,由于特异性PCR仅检测预定的靶标,因此会漏掉新的病毒株或常规测试板中未包含的病毒。近来,高通量测序的进展允许在临床样品中对整个病毒种群进行病毒序列无关的鉴定,但是需要标准化的方案以允许在临床诊断中广泛应用。在这里,我们描述了使用来自临床样品的总核酸的随机扩增的高通量宏基因组病毒测序的全面样品制备方案。结果为了优化宏基因组测序以用于病毒诊断,我们对掺有RNA和DNA病毒的血浆样品测试了不同的富集和扩增程序。包括过滤,核酸酶消化以及在单独的反应中随机扩增RNA和DNA的方案可提供最佳结果,从而可以可靠地恢复病毒基因组,并使测序读数的相对数量与病毒输入有良好的相关性。我们通过对包含多种来自不同病毒家族的人类病毒的多重病毒病原体试剂进行测序,进一步验证了我们的方法。我们的方法被证明可以成功地检测出大多数包含高读取数的病毒,并且与通过相同参考试剂验证的本领域其他方案进行了比较。我们的测序方案不仅适用于血浆,而且适用于其他临床样品,例如尿液和咽喉拭子。结论我们建立的病毒宏基因组测序工作流程在检测不同临床样品中的各种病毒方面被证明是成功的。我们的协议补充了现有的特定于病毒的检测策略,从而提供了机会来识别通常在常规诊断专家组中未解决的非典型和新型病毒。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号